# CAIN42 — Investor / IP Value Report (Prompt 13)

> **Internal analytical estimate. NOT an appraisal, NOT a financing valuation, NOT a guarantee.** CAIN-42 is
> pre-revenue, has no incorporation record, and has no patent filed or granted. Figures below separate bases and must
> not be added together.

## Observed technical value

- `cain/ironclad/` + `cain/dynasty/` + `cain/continuum/`: production-shaped substrate, **97/97** formal properties,
  **53/53** governance mutations killed, 100k fault-injection and 100k population lab cases clean, 48/48 live wire
  probes. Same-project evidence only.

## Replacement-cost value

Reimplementing the authority→effect→verification substrate with tests, mutation suites and live integration is a
multi-engineer-quarter effort; replacement cost of the *code* alone is modest (low six figures) — the scarce asset is
the integrated boundary, not the line count.

## Maximum evidence-backed IP value

- **Prompt 6-11 base ≈ $843,300; Prompt 6-12 ≈ $1,980,700; Prompt 6-13 maximum ≈ $2,587,900**
  (range ≈ $1,105,900 – $4,756,250). Register method: gross tier anchors → blended prior-art/deployment discount.

## Company / founder scenario (premium held at registered level)

- Investor base ≈ $4,319,900; strategic base ≈ $5,319,900; Vicente Fernando Noriega (100% owner, PAPER equity, not cash)
  base ≈ $4,319,900. See `artifacts/valuation/CAIN_PROMPT13_IP_VALUE_RECALC.md` for exact figures.

## What prevents a higher value (the honest answer)

No paying customer, no third-party security audit, no filed patents, no incorporation/IP assignment, no downstream
execution binding, no soak. Each is an evidence gap, not a code gap.

## Shortest path to increase defensible value

1. Bind one customer's downstream execution to the effect receipt (MCPGate) → moves EFFECT_VERIFY to ENFORCED.
2. One paid pilot / audit engagement (Tier-1 revenue path).
3. A clean 72-hour soak of the effect stages.
4. File PP-03 (optionality), incorporating with IP assignment.
